228 related articles for article (PubMed ID: 26195367)
1. Re: The Value of Magnetic Resonance Imaging in the Detection of Prostate Cancer in Patients with Previous Negative Biopsies and Elevated Prostate-Specific Antigen Levels: A Meta-Analysis.
Siegel C
J Urol; 2015 Aug; 194(2):395. PubMed ID: 26195367
[No Abstract] [Full Text] [Related]
2. The value of magnetic resonance imaging in the detection of prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels: a meta-analysis.
Zhang ZX; Yang J; Zhang CZ; Li KA; Quan QM; Wang XF; Wang H; Zhang GX
Acad Radiol; 2014 May; 21(5):578-89. PubMed ID: 24703470
[TBL] [Abstract][Full Text] [Related]
3. Re: The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men.
Taneja SS
J Urol; 2015 Jan; 193(1):127. PubMed ID: 25523657
[No Abstract] [Full Text] [Related]
4. Prostate specific antigen testing: age-related interpretation in early prostate cancer detection.
McKenzie PR; Delahunt B; Kench JG; Ross B; Lam Q; deVoss K; Tran HA; Sikaris KA
Pathology; 2013 Jun; 45(4):343-5. PubMed ID: 23619589
[No Abstract] [Full Text] [Related]
5. [PSA and blood test diagnostics of prostate cancer].
Seikkula H; Pettersson K; Boström PJ
Duodecim; 2015; 131(17):1547-52. PubMed ID: 26548101
[TBL] [Abstract][Full Text] [Related]
6. Prostate detection possibility.
Gunby P
JAMA; 1999 Jun 23-30; 281(24):2274-5. PubMed ID: 10386541
[No Abstract] [Full Text] [Related]
7. Time to replace prostate-specific antigen (PSA) with the Prostate Health Index (PHI)? Yet more evidence that the PHI consistently outperforms PSA across diverse populations.
Loeb S
BJU Int; 2015 Apr; 115(4):500. PubMed ID: 25808708
[No Abstract] [Full Text] [Related]
8. Valentine's Day PSA.
Dasgupta P
BJU Int; 2014 Feb; 113(2):177. PubMed ID: 24712694
[No Abstract] [Full Text] [Related]
9. Prostate-specific antigen and other prostate cancer markers.
Stenman U; Finne P; Zhang W; Leinonen J
Urology; 2000 Dec; 56(6):893-8. PubMed ID: 11113726
[No Abstract] [Full Text] [Related]
10. Prostate Health Index (PHI): golden bullet or just another prostate cancer marker?
Loeb S
Eur Urol; 2013 Jun; 63(6):995-6; discussion 996-7. PubMed ID: 23453055
[No Abstract] [Full Text] [Related]
11. 4-Kallikrein Test and Kallikrein Markers in Prostate Cancer Screening.
McDonald ML; Parsons JK
Urol Clin North Am; 2016 Feb; 43(1):39-46. PubMed ID: 26614027
[TBL] [Abstract][Full Text] [Related]
12. Value of a Statistical Model Based on Four Kallikrein Markers in Blood, Commercially Available as 4Kscore, in All Reasonable Prostate Biopsy Subgroups.
Vickers AJ; Vertosick EA; Sjoberg DD
Eur Urol; 2018 Oct; 74(4):535-536. PubMed ID: 29903434
[No Abstract] [Full Text] [Related]
13. The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels.
Lawrentschuk N; Fleshner N
BJU Int; 2009 Mar; 103(6):730-3. PubMed ID: 19154475
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen and other serum and urine markers in prostate cancer.
Stephan C; Ralla B; Jung K
Biochim Biophys Acta; 2014 Aug; 1846(1):99-112. PubMed ID: 24727384
[TBL] [Abstract][Full Text] [Related]
15. The Problem Is Not What to Do with Indolent and Harmless Prostate Cancer-The Problem Is How to Avoid Finding These Cancers.
Gandaglia G; Briganti A; Fossati N; Salonia A; Mottrie A; Catto J; Montorsi F
Eur Urol; 2016 Oct; 70(4):547-548. PubMed ID: 26916048
[TBL] [Abstract][Full Text] [Related]
16. Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study.
Bryant RJ; Sjoberg DD; Vickers AJ; Robinson MC; Kumar R; Marsden L; Davis M; Scardino PT; Donovan J; Neal DE; Lilja H; Hamdy FC
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863334
[TBL] [Abstract][Full Text] [Related]
17. Should we screen for prostate cancer? A re-examination of the evidence.
Del Mar CB; Glasziou PP; Hirst GH; Wright RG; Hoffmann TC
Med J Aust; 2013 Jun; 198(10):525-7. PubMed ID: 23725255
[No Abstract] [Full Text] [Related]
18. Words of wisdom. Re: PSA density improves prediction of prostate cancer.
Roobol MJ
Eur Urol; 2014 Nov; 66(5):964-5. PubMed ID: 25763443
[No Abstract] [Full Text] [Related]
19. [Detection of prostate cancer. German guideline recommends opportunist screening].
Arnheim K
MMW Fortschr Med; 2010 Sep; 152(39):12-3. PubMed ID: 21058430
[No Abstract] [Full Text] [Related]
20. Future of screening for prostate cancer.
Dahm P
BMJ; 2017 Sep; 358():j4200. PubMed ID: 28928226
[No Abstract] [Full Text] [Related]
[Next] [New Search]
